Pert 2 in 1

Manufacturer
Sodalis USA, LLC
Effective date
2025-07-30
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 01:09:25

Label at a glance#

ProductPert 2 in 1 Extra Strength
Active ingredientSALICYLIC ACID
Label structure9 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active ingredient

Salicylic Acid 3%

OTC - PURPOSE SECTION

Purpose

Antidandruff

INDICATIONS & USAGE SECTION

Use Controls the symptoms of dandruff

WARNINGS SECTION

Warnings

For external use only

OTC - WHEN USING SECTION

When using this product

  • avoid contact with eyes. If contact occurs, rinse eyes thoroughly with water.

OTC - STOP USE SECTION

Stop use and ask a doctor if

  • condition worsens or does not improve after regular use of this product as directed.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

DOSAGE & ADMINISTRATION SECTION

Directions

  • For best results, use at least twice a week or as directed by a doctor.
  • Shake before use.
  • Gently massage into wet hair and scalp, lather and rinse. Repeat if desired.

INACTIVE INGREDIENT SECTION

Inactive ingredients: Water (aqua), sodium laureth sulfate, sodium lauryl sulfate, cocamidopropyl betaine, glycerin, cocamide MEA, dimethicone, glycol distearate, fragrance (parfum), guar hydroxypropyltrimonium chloride, sodium citrate, acrylates/C10-30 alkyl acrylate crosspolymer, sodium benzoate, sodium chloride, methylchloroisothiazolinone, methylisothiazolinone, sodium hydroxide, D&C Yellow no. 10, FD&C Blue no. 1

OTC - QUESTIONS SECTION

Questions or Comments?

1-800-575-7960 www.pert.com

SPL UNCLASSIFIED SECTION

Distributed by: Sodalis USA, LLC.

Westport, CT 06880

pert.com • 1-800-575-7960

Pert is a registeed trademark of Sodalis USA, LLC.

Made in Canada.

400248BL2

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

PERT®

EXTRA STRENGTH*

ANTI-DANDRUFF

2 IN 1

With 3% Salicylic Acid
QUAD ACTION FORMULA

  • Cleans
  • Conditions
  • Reduces Flakes
  • Fights Odors

SHAMPOO+CONDITIONER

12 FL OZ (355 mL)

labellabel

drug factsdrug facts

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
205023salicylic acid 3 % Medicated ShampooPSN2
205023salicylic acid 30 MG/ML Medicated ShampooSCD2
205023salicylic acid 3 % Medicated ShampooSY2

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
c6f86816-7da6-43ea-8c25-ac9758311cc5Product name120220118
dea2eded-d1e7-46bb-9a3d-f8dc20de6277Product name120190408
252e11b6-1a9a-4283-a242-df2c129c496dProduct name320170717
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
81277-803-12Pert 2 in 1Extra Strength355 mL in 1 BOTTLESHAMPOO3552

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 20 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
81277-80381277-803-12

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 19 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Pert 2 in 1 Extra StrengthSALICYLIC ACIDSodalis USA, LLC25c8a46c-4400-709f-e063-6394a90a3f312025-07-30WarningsExact identifier
ndc (package): 81277-803-12
ndc (product): 81277-803
ndc11 (package): 81277080312
spl id: 3ba3f0a1-4214-b7c6-e063-6294a90adbb4
spl set id: 25c8a46c-4400-709f-e063-6394a90a3f31

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.